Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jelena V. Jovanovic"'
Autor:
Nigel H. Russell, David Grimwade, Michael Dennis, Richard Dillon, Nicola Foot, Sandrine Jayne, Nicola E. Potter, Kavita Raj, Mikel Valganon, Matthew J. Ahearne, Lynn Quek, Sudhir Tauro, Jelena V. Jovanovic, Ellen Solomon, Martin J. S. Dyer
Publikováno v:
Leukemia
Autor:
Jelena V. Jovanovic, Michael Dennis, Manohursingh Runglall, Nicola E. Potter, Anju Kanda, Pramila Krishnamurthy, Igor Novitzky-Basso, Anjum Bashir Khan, Emmanouil Nikolousis, Alan Kenneth Burnett, Robert Kerrin Hills, Samah Alimam, David Grimwade, Ulrik Malthe Overgaard, Charles Craddock, Rosemary E. Gale, Asim Khwaja, Kate Hill, Richard Dillon, Nicola Foot, Adam Ivey, Rahuman Salim, Priyanka Mehta, Damian Finnegan, Erin Hurst, Amanda F. Gilkes, Sylvie D. Freeman, Matthew Lee Smith, David Taussig, Steven Knapper, Nigel H. Russell, Jamie Cavenagh, Mikel Valganon, Ruth Spearing, Hans Beier Ommen, Robert Danby, Kavita Raj, Harpreet Kaur, Peter R. E. Johnson
Publikováno v:
Dillon, R, Hills, R K, Freeman, S D, Potter, N, Jovanovic, J, Ivey, A, Kanda, A, Runglall, M, Foot, N, Valganon, M, Khwaja, A, Cavenagh, J, Smith, M L, Ommen, H B, Overgaard, U, Dennis, M, Knapper, S, Kaur, H, Taussig, D C, Mehta, P, Raj, K, Novitzky-Basso, I, Nikolousis, E, Danby, R D, Krishnamurthy, P, Hill, K, Finnegan, D, Alimam, S, Hurst, E, Johnson, P, Khan, A B, Salim, R, Craddock, C F, Spearing, R L, Gilkes, A F, Gale, R E, Burnett, A K, Russell, N H & Grimwade, D 2020, ' Molecular MRD status and outcome after transplantation in NPM1 mutated AML ', Blood, vol. 135, no. 9, pp. 680-688 . https://doi.org/10.1182/blood.2019002959
Dillon, R, Hills, R, Freeman, S, Potter, N, Jovanovic, J, Ivey, A, Kanda, A S, Runglall, M, Foot, N, Valganon, M, Khwaja, A, Cavenagh, J, Smith, M, Ommen, H B, Overgaard, U M, Dennis, M, Knapper, S, Kaur, H, Taussig, D, Mehta, P, Raj, K, Novitzky-Basso, I, Nikolousis, E, Danby, R, Krishnamurthy, P, Hill, K, Finnegan, D, Alimam, S, Hurst, E, Johnson, P, Khan, A, Salim, R, Craddock, C, Spearing, R, Gilkes, A, Gale, R, Burnett, A, Russell, N H & Grimwade, D 2020, ' Molecular MRD status and outcome after transplantation in NPM1-mutated AML ', Blood, vol. 135, no. 9, pp. 680-688 . https://doi.org/10.1182/blood.2019002959
Dillon, R, Hills, R, Freeman, S, Potter, N, Jovanovic, J, Ivey, A, Kanda, A S, Runglall, M, Foot, N, Valganon, M, Khwaja, A, Cavenagh, J, Smith, M, Ommen, H B, Overgaard, U M, Dennis, M, Knapper, S, Kaur, H, Taussig, D, Mehta, P, Raj, K, Novitzky-Basso, I, Nikolousis, E, Danby, R, Krishnamurthy, P, Hill, K, Finnegan, D, Alimam, S, Hurst, E, Johnson, P, Khan, A, Salim, R, Craddock, C, Spearing, R, Gilkes, A, Gale, R, Burnett, A, Russell, N H & Grimwade, D 2020, ' Molecular MRD status and outcome after transplantation in NPM1-mutated AML ', Blood, vol. 135, no. 9, pp. 680-688 . https://doi.org/10.1182/blood.2019002959
Relapse remains the most common cause of treatment failure for patients with acute myeloid leukemia (AML) who undergo allogeneic stem cell transplantation (alloSCT), and carries a grave prognosis. Multiple studies have identified the presence of meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b21c643cbf633633d68fcbce8813cce
https://kclpure.kcl.ac.uk/en/publications/16321efb-66e2-4258-8991-eac3a8316f55
https://kclpure.kcl.ac.uk/en/publications/16321efb-66e2-4258-8991-eac3a8316f55
Autor:
Jelena V Jovanovic, Kristian eRennie, Dominic eCulligan, Andrew ePeniket, Anne eLennard, Justin eHarrison, Paresh eVyas, David eGrimwade
Publikováno v:
Frontiers in Oncology, Vol 1 (2011)
Molecular detection of minimal residual disease (MRD) has become established to assess remission status and guide therapy in patients with PML-RARA+ acute promyelocytic leukemia (APL). However, there are few data on tracking disease response in patie
Externí odkaz:
https://doaj.org/article/22ab3d047e494d679621329cc6844c90
Autor:
Robert Kerrin Hills, Sophie Betteridge, Michael Dennis, Nigel H. Russell, Jelena V. Jovanovic, David Grimwade, Richard Dillon, Alan Kenneth Burnett
Publikováno v:
Russell, N, Burnett, A, Hills, R, Betteridge, S, Dennis, M, Jovanovic, J, Dillon, R & Grimwade, D 2018, ' Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL : long-term follow-up of the AML17 trial ', Blood, vol. 132, no. 13, pp. 1452-1454 . https://doi.org/10.1182/blood-2018-05-851824
We have previously reported on the results of the United Kingdom National Cancer Research Institute (NCRI) AML17 trial, which, for acute promyelocytic leukemia (APL) of all risk groups, compared anthracycline + all-trans retinoic acid (ATRA) (AIDA) v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc11a6974164a42acbe0ff41c4475eb6
https://doi.org/10.1182/blood-2018-05-851824
https://doi.org/10.1182/blood-2018-05-851824
Autor:
Beki James, Persis Amrolia, Arnaud Petit, Manohursingh Runglall, Brenda Gibson, Andrew S. Moore, Jelena V. Jovanovic, Paresh Vyas, Keith Wheatley, Nicholas B. Heaney, Anju Kanda, Owen P. Smith, Hélène Lapillonne, Guy Leverger, Richard Dillon, André Baruchel, Yves Bertrand, Pamela Kearns, Nicola E. Potter, Paul Virgo, Gérard Michel, Aimee Jackson, Anna Lawson, Jean-Hugues Dalle, Geoff Shenton, Claude Preudhomme, Christine J. Harrison, Katharine Patrick, Claire Schwab
Publikováno v:
Blood. 134:1393-1393
Introduction Most children with acute myeloid leukaemia (AML) harbour fusion genes which are ideal targets for molecular minimal residual disease (MRD) monitoring. However, evidence of prognostic significance is currently lacking and consequently mos
Autor:
Richard Dillon, Nicola Foot, Manohursingh Runglall, Nigel H. Russell, Nicola E. Potter, David Taussig, Tse-Chieh Teh, Steven Knapper, Ing Soo Tiong, Anju Kanda, Catherine Vassili, Vanessa Roma Donati, Mikel Valganon, Kavita Raj, Jelena V. Jovanovic, Andrew Grigg, Andrew H. Wei, Adam Ivey, Anthony P. Schwarer, Chun Yew Fong
Publikováno v:
Blood. 134:2648-2648
Introduction: Molecular MRD monitoring in NPM1 mutant (mut) AML is now standard of care in many countries as prospective clinical trials have demonstrated that suboptimal reduction and/or rising levels of NPM1mut transcript are associated with diseas
Autor:
Marcos González Díaz, R. G. Sanz, Edwige Voisset, David Grimwade, Christelle Vincent-Fabert, Richard Dillon, Ana Africa Martín López, Jelena V. Jovanovic, M C Chillón, Estelle Duprez, Yvonne G Morgan, Norma C. Gutiérrez, Eskinder Solomon, J. Lok
Publikováno v:
Leukemia
Leukemia, 2017, 31 (3), pp.747-751. ⟨10.1038/leu.2016.338⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (3), pp.747-751. ⟨10.1038/leu.2016.338⟩
Leukemia, 2017, 31 (3), pp.747-751. ⟨10.1038/leu.2016.338⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (3), pp.747-751. ⟨10.1038/leu.2016.338⟩
Letter to the Editor.
These data were presented in part at the 56th American Society of Hematology meeting, San Francisco, December 2014.
These data were presented in part at the 56th American Society of Hematology meeting, San Francisco, December 2014.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56a6d9e13c219c7fb95d530fef5c7a9
https://hal.science/hal-01789885
https://hal.science/hal-01789885
Autor:
Sameena Iqbal, David Grimwade, Bryan D. Young, Floriana Manodoro, Jelena V. Jovanovic, Silvana Debernardi, Jun Wang, Tracy Chaplin, Farideh Miraki-Moud, John G. Gribben, Jacek Marzec, Eva Moravcsik, David Taussig
Publikováno v:
Blood. 123:2066-2074
Distinct patterns of DNA methylation characterize the epigenetic landscape of promyelocytic leukemia/retinoic acid receptor-α (PML-RARα)-associated acute promyelocytic leukemia (APL). We previously reported that the microRNAs (miRNAs) clustered on
Publikováno v:
Best Practice & Research Clinical Haematology. 27:53-61
Molecularly targeted therapies have transformed the management of PML-RARA+ acute promyelocytic leukaemia (APL), with survival rates now exceeding 80% in clinical trials. This raises questions about the relevance of post-remission monitoring for PML-
Autor:
Nicola E. Potter, Jelena V. Jovanovic, David Grimwade, Anju Kanda, Sylvie D. Freeman, Adam Ivey, A Khwaja, Richard Dillon, Nicola Foot, Laura Upton, Robert Kerrin Hills, Nigel H. Russell, Manohursingh Runglall, Jamie Cavenagh, Ruth Spearing, Alan Kenneth Burnett
Publikováno v:
Blood. 132:2739-2739
Introduction Relapse remains the most common cause of treatment failure for patients with acute myeloid leukaemia (AML) who undergo allogeneic stem cell transplantation (SCT) and carries a grave prognosis. Multiple studies have identified the presenc